Patient Outcomes Linked To Biomarker Levels

JonN writes to tell us Science Daily is reporting that researchers at Yale University have discovered that current pathology methods for biomarker detection can be dramatically altered depending on the concentration of antibodies used. From the article: "Biomarkers may have the power to provide diagnostic, therapeutic, and prognostic information for personalized medicine." said Donald Earl Henson, M.D., of the George Washington University Cancer Institute, in "Back to the Drawing Board on Immunohistochemistry and Predictive Factors," an accompanying editorial. "However, immunohistochemistry, a popular technique for evaluating biomarker expression, may contain procedural flaws that jeopardize its promise."

Comments

On my powerbook, that "i" in the title

[antifoidulus]

looks a lot like an "l" causing me to read it as "blomarker". I guess my overall health would be greatly improved if women would help raise my "blomarker" level too :P